Efficacy of Huoxue Qianyang Qutan Recipe on essential hypertension: A randomized, double-blind, placebo-controlled trial

医学 血压 内科学 中医药 肌酐 安慰剂 血瘀 体质指数 随机对照试验 甘油三酯 胃肠病学 传统医学 胆固醇 病理 替代医学
作者
Jun Xie,Yu-long Ma,Mingtai Gui,Lei Yao,Jianhua Li,Mingzhu Wang,Xunjie Zhou,Yifan Wang,Mingyi Zhao,Hui Cao,Bo Lü,Deyu Fu
出处
期刊:Journal of Chinese Integrative Medicine [Elsevier BV]
卷期号:22 (4): 484-492 被引量:5
标识
DOI:10.1016/j.joim.2024.05.002
摘要

Hypertension, a prevalent disease, is a significant risk factor for coronary heart disease. Huoxue Qianyang Qutan Recipe (HQQR), a traditional Chinese herbal remedy, has been used for treating hypertension over several years. This study assesses HQQR's efficacy for controlling blood pressure among patients with hypertension related to blood stasis, yang hyperactivity and phlegm. Design, setting, participants and interventions: A randomized controlled trial was conducted at the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, China, from July 2020 to June 2022. Major components of HQQR were identified using thin-layer chromatography and high-performance liquid chromatography. Participants aged 18–80 years, exhibiting traditional Chinese medicine syndromes of blood stasis, yang hyperactivity or phlegm, along with grades 1 or 2 hypertension, were randomly categorized into two groups. The intervention group was given HQQR granules alongside conventional hypertension treatment, while the control group was given placebo granules in addition to conventional treatment for 12 weeks. Main outcome measures: The primary outcome was clinic blood pressure, whereas secondary outcomes included metabolic indices (e.g., homeostasis model assessment of insulin resistance [HOMA-IR], total cholesterol [TC], low-density lipoprotein cholesterol and triglyceride), target organ damage indices (left ventricular mass index and urinary albumin creatinine ratio [UACR]) and inflammation indices (interleukin-6 [IL-6] and high-sensitivity C-reactive protein [hs-CRP]). HQQR's primary components were identified as salvianolic acid B, emodin and ferulic acid. Of the 216 participants (108 in each group), compared to the control, the intervention group exhibited significant improvements (P < 0.001) in clinic systolic blood pressure ([136.24 ± 7.63] vs [130.06 ± 8.50] mmHg), clinic diastolic blood pressure ([84.34 ± 8.72] vs [80.46 ± 6.05] mmHg), home systolic blood pressure ([131.64 ± 8.74] vs [122.36 ± 8.45] mmHg) and home diastolic blood pressure ([78.47 ± 9.53] vs [71.79 ± 6.82] mmHg). HQQR demonstrated a reduction in ambulatory blood pressure (24-hour systolic blood pressure: [133.75 ± 10.49] vs [132.46 ± 8.84] mmHg and 24-hour diastolic blood pressure: [84.12±8.01] vs [82.11±7.45] mmHg) and an improvement in HOMA-IR ([4.09 ± 1.72] vs [3.98 ± 1.44]), TC ([4.66 ± 1.47] vs [3.75 ± 1.81] mmol/L) and UACR (75.94 [5.12, 401.12] vs 45.61 [4.26, 234.26]). Moreover, HQQR demonstrated a decrease in hs-CRP (1.46 [0.10, 10.53] vs 0.57 [0.12, 3.99] mg/L) and IL-6 (6.69 [2.00, 29.74] vs 5.27 [2.00, 9.73] pg/mL), with no reported side effects (P < 0.001). This study highlights the therapeutic potential of HQQR use in ameliorating blood pressure, glycolipid metabolism, and inflammation in patients with hypertension. Trial registration: ChiCTR2000035092 (http://www.chictr.org.cn/). Please cite this article as: Xie J, Ma YL, Gui MT, Yao L, Li JH, Wang MZ, Zhou XJ, Wang YF, Zhao MY, Cao H, Lu B, Fu DY. Efficacy of Huoxue Qianyang Qutan Recipe on essential hypertension: A randomized, double-blind, placebo-controlled trial. J Integr Med. 2024; Epub ahead of print.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sjx发布了新的文献求助10
刚刚
完美世界的应助被lhy采纳,获得10
刚刚
gaoyingxin发布了新的文献求助30
刚刚
小明同学发布了新的文献求助10
1秒前
yyc完成签到,获得积分20
1秒前
小蘑菇的应助被wzg666采纳,获得10
1秒前
半斤酒才完成签到,获得积分10
1秒前
老迟到的连虎完成签到,获得积分10
1秒前
lili发布了新的文献求助10
2秒前
酷酷的鸿完成签到,获得积分10
3秒前
Enfant发布了新的文献求助10
3秒前
3秒前
3秒前
张伟发布了新的文献求助10
3秒前
4秒前
junge发布了新的文献求助10
4秒前
科研通AI6.3的应助被KK采纳,获得40
4秒前
情怀的应助被Aaron采纳,获得10
5秒前
5秒前
成霜完成签到,获得积分10
5秒前
脑洞疼的应助被张张采纳,获得10
5秒前
xx完成签到 ,获得积分10
5秒前
无限的含羞草完成签到,获得积分10
5秒前
qqqq完成签到,获得积分10
5秒前
楚留香完成签到,获得积分10
6秒前
6秒前
筱筱发布了新的文献求助200
7秒前
7秒前
王小冉发布了新的文献求助10
7秒前
7秒前
7秒前
鼻毛好胜完成签到,获得积分10
8秒前
flos完成签到,获得积分10
8秒前
JenifferF完成签到,获得积分10
8秒前
9秒前
千里眼发布了新的文献求助10
10秒前
团子完成签到,获得积分10
10秒前
舒适飞薇发布了新的文献求助10
10秒前
拼搏的亦丝完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186261
求助须知:如何正确求助?哪些是违规求助? 9574697
关于积分的说明 21837731
捐赠科研通 7783915
什么是DOI,文献DOI怎么找? 3434752
关于科研通互助平台的介绍 2559109
邀请新用户注册赠送积分活动 2481528